LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinomaJie Wu, Xuejun Hu, Chunlei Zheng et al.|Biomarker Research|2021Cited by 45
Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2Chen Yang, Xuejun Hu, Hongfei Yan et al.|Pharmacological Research|2020Cited by 34
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung AdenocarcinomaCheng Yang, Xiaofang Che, Kezuo Hou et al.|Frontiers in Oncology|2021Cited by 33
Loss of G-protein-signaling modulator 2 accelerates proliferation of lung adenocarcinoma via EGFR signaling pathwayMingming Deng, Xuejun Hu, Bofang Liu et al.|The International Journal of Biochemistry & Cell Biology|2020Cited by 27
Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib‑resistant non‑small cell lung cancer cellsYang� Yang, Jingdong Zhang, Yizhe Wang et al.|Oncology Letters|2021Cited by 22